Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
15089-6 Phospholipid SCnc Ser/Plas Pt Qn     ACTIVE Phospholipid [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     mmol/L             CHEM   15089-6         Both       0 Phospholipid SerPl-sCnc       Y   Chemistry; Level; Lipid; Phoslpd; Phospholipids; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.4 1.0k               mmol/L       0
1509-9 Glucose^1H post 75 g glucose PO MCnc Urine Pt Qn     ACTIVE Glucose [Mass/volume] in Urine --1 hour post 75 g glucose PO   MIN DefinitionDescription     mg/dL             CHAL   1509-9         Both       0 Glucose 1h p 75 g Glc PO Ur-mCnc       Y   1 hour; 1.0Hr; 1h p 75 g Glc PO; 60 min; 60 minutes; 60M; 60min; 75Gm; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p 75 g Glc PO; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.73 1               mg/dL       0
15090-4 Porphyrins SRat Stool 24H Qn     ACTIVE Porphyrins [Moles/time] in 24 hour Stool   MIN DefinitionDescription     umol/24 H             CHEM   15090-4         Observation       0 Porphyrins 24h Stl-sRate       Y   1 day; 24 hours; 24HR; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Hematology; Heme; Porph; Porphyrin; QNT; Quan; Quant; Quantitative; sRate; Stl; Stool = Fecal; Substance Rate 2.42 1.0k               umol/(24.h)       0
15091-2 Pregnanediol SCnc Urine Pt Qn     ACTIVE Pregnanediol [Moles/volume] in Urine   MIN DefinitionDescription     umol/L             CHEM   15091-2         Both       0 Pregnanediol Ur-sCnc       Y   Chemistry; Level; Point in time; Pregnanedi; PTL; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn 2.42 1.0k               umol/L       0
15092-0 Pregnanetriol SCnc Urine Pt Qn     ACTIVE Pregnanetriol [Moles/volume] in Urine   MIN DefinitionDescription     umol/L             CHEM   15092-0         Both       0 Pregntrl Ur-sCnc       Y   Chemistry; Level; Point in time; Pregnanetr; Pregntrl; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn 2.58 1.0k               umol/L       0
15093-8 Protoporphyrin.free SCnc Bld Pt Qn     ACTIVE Protoporphyrin Free [Moles/volume] in Blood   MIN DefinitionDescription     nmol/L             CHEM   15093-8         Observation       0 FEP Bld-sCnc       Y   Blood; Chemistry; Dicarboxyl porphyrin; Dicarboxylporphyrin; FEP; FR; Free erythrocyte protoporphyrin; Hematology; Heme; Level; Non-protein bound; Point in time; Protoporph; Protoporphrn; Protoporphyrins; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood 2.73 1.0k               nmol/L       0
15094-6 Testosterone SCnc Urine Pt Qn     ACTIVE Testosterone [Moles/volume] in Urine   MIN DefinitionDescription     umol/L             CHEM   15094-6         Both       0 Testost Ur-sCnc       Y   Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Testo; Testos; Testost; UA; UR; Urn 2.42 1.0k               umol/L       0
15095-3 Testosterone SRat Urine 24H Qn     ACTIVE Testosterone [Moles/time] in 24 hour Urine   MIN DefinitionDescription     umol/24 H             CHEM   15095-3         Both       0 Testost 24h Ur-sRate       Y   1 day; 24 hours; 24HR; Chemistry; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; Testo; Testos; Testost; UA; UR; Urn 2.42 1.0k               umol/(24.h)       0
15096-1 Uroporphyrin SRat Urine 24H Qn     ACTIVE Uroporphyrin [Moles/time] in 24 hour Urine   MIN DefinitionDescription     nmol/24 H             CHEM   15096-1         Observation       0 Uropor 24h Ur-sRate       Y   1 day; 24 hours; 24HR; Chemistry; Hematology; Heme; Octacarboxyl porphyrin; Octacarboxylporphyrin; Octacarboxyphyrin; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn; Urophorph 2.73 1.0k               nmol/(24.h)       0
15097-9 Vanillylmandelate SCnc Urine Pt Qn     ACTIVE Vanillylmandelate [Moles/volume] in Urine   MIN DefinitionDescription     umol/L             CHEM   15097-9         Both       0 VMA Ur-sCnc       Y   3-methoxy-4-hydroxymandelate; 3-methyl,4-hydroxy mandelate; 3-methyl,4-oh mandelic acid; Catecholamine metabolite; Chemistry; HMMA; Hydroxy-methoxy-mandelate; Hydroxy-methoxy-mandelic acid; Level; MHMA; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Tumor marker; UA; UR; Urn; Vanillylmandelic acid; Vanilmandelate; VMA 2.73 1.0k               umol/L       0
15098-7 Amikacin^random SCnc Ser/Plas Pt Qn     DISCOURAGED Amikacin [Moles/volume] in Serum or Plasma --random   MIN DefinitionDescription     umol/L             DRUG/TOX   15098-7         Both       0 Amikacin Rand SerPl-sCnc       Y   Amikin; Aminoglycosides; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Rand; Rando; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
15099-5 Amiodarone SCnc Ser/Plas Pt Qn     ACTIVE Amiodarone [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             DRUG/TOX   15099-5         Both       0 Amiodarone SerPl-sCnc       Y   Cordarone; DRUG/TOXICOLOGY; Drugs; Level; Pacerone; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k               umol/L       0
151-1 Cephalexin Titr Isolate+Ser Pt SemiQn SBT   ACTIVE Cephalexin [Susceptibility] by Serum bactericidal titer   MAJ DefinitionDescription     titer             ABXBACT   151-1   SBT     Observation       0 Cephalexin Titr SBT           ANTIBIOTIC SUSCEPTIBILITIES; Cefadine; Dilution factor; Dilution Factor (Titer); GRACEF; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Keflex; Losporal; Palitrex; Point in time; Random; Salitex; Sequence based typing; Serum; SERUM BACTERICIDAL TITER; Serum killing test; SmQn; SR; Titer; Titered; Titre; Ttr 2.75 1               {titer}       0
1510-7 Glucose^1H post dose insulin IV MCnc Ser/Plas Pt Qn     ACTIVE Glucose [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV   MIN DefinitionDescription     mg/dL             CHAL   1510-7         Both       0 Glucose 1h p Ins IV SerPl-mCnc       Y   1 hour; 1.0Hr; 1h p Ins IV; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente 2.73 1               mg/dL       0
15100-1 Barbiturates SCnc Ser/Plas Pt Qn     ACTIVE Barbiturates [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             DRUG/TOX   15100-1         Both       0 Barbiturates SerPl-sCnc       Y   Addiction; Barb; Barbiturate; Barbs; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k               umol/L       0
15101-9 Chloramphenicol SCnc Ser/Plas Pt Qn     ACTIVE Chloramphenicol [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             DRUG/TOX   15101-9         Both       0 Chloramphen SerPl-sCnc       Y   Amphicol; Biophenicol; c225; Chloramphen; Chloromycetin; DRUG/TOXICOLOGY; Drugs; Level; Mychel; Paraxin; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k               umol/L       0
15102-7 Codeine SCnc Ser/Plas Pt Qn     ACTIVE Codeine [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             DRUG/TOX   15102-7         Both       0 Codeine SerPl-sCnc       Y   Addiction; c260; C300; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Methylmorphine; Morphine methyl ether; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.4 1.0k               umol/L       0
15103-5 cycloSPORINE SCnc Ser Pt Qn     DISCOURAGED cycloSPORINE [Moles/volume] in Serum   MIN DefinitionDescription     umol/L             DRUG/TOX   15103-5         Both       0 cycloSPORINE Ser-sCnc       Y   Ciclosporin; Ciclosporine; CsA; Cyclosporin a; Cyclosporins; DRUG/TOXICOLOGY; Drugs; Gengraf; Level; Neoral; Point in time; QNT; Quan; Quant; Quantitative; Random; Restasis; Sandimmune; SangCya; Serum; SR; Substance concentration 2.73 1.0k       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
15104-3 Digitoxin SCnc Ser/Plas Pt Qn     ACTIVE Digitoxin [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             DRUG/TOX   15104-3         Both       0 Digitoxin SerPl-sCnc       Y   Crystidigin; Crystodigin; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; Purodigin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.42 1.0k               umol/L       0
15105-0 Flecainide SCnc Ser/Plas Pt Qn     ACTIVE Flecainide [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             DRUG/TOX   15105-0         Both       0 Flecainide SerPl-sCnc       Y   DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tambocor 2.42 1.0k               umol/L       0
15106-8 Gentamicin^random SCnc Ser/Plas Pt Qn     DISCOURAGED Gentamicin [Moles/volume] in Serum or Plasma --random   MIN DefinitionDescription     umol/L             DRUG/TOX   15106-8         Both       0 Gentamicin Rand SerPl-sCnc       Y   Aminoglycosides; c213; DRUG/TOXICOLOGY; Drugs; Garamycin; Genirr; Genj; Gent; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Rand; Rando; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
15107-6 Imipramine SCnc Ser/Plas Pt Qn     ACTIVE Imipramine [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     nmol/L             DRUG/TOX   15107-6         Both       0 Imipramine SerPl-sCnc       Y   DRUG/TOXICOLOGY; Drugs; Imipra; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tofranil 2.34 1.0k               nmol/L       0
15108-4 Methadone SCnc Ser/Plas Pt Qn     ACTIVE Methadone [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             DRUG/TOX   15108-4         Both       0 Methadone SerPl-sCnc       Y   Addiction; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; METD; Methadose; MTD; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k               umol/L       0
15109-2 Midazolam SCnc Ser/Plas Pt Qn     ACTIVE Midazolam [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             DRUG/TOX   15109-2         Both       0 Midazolam SerPl-sCnc       Y   DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Versed 2.42 1.0k               umol/L       0
1511-5 Glucose^1H post dose U/kg insulin IV MCnc Plas Pt Qn     DEPRECATED Deprecated Glucose [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV   DEL DefinitionDescription                   CHAL   1511-5                 0 Deprecated Glucose 1H p U/kg Ins IV Plas           1 hour; 1.0Hr; 1h p U/kg Ins IV; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; Sliding; Ultralente 2.36 1       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
104,672 results found